Carbohydrate recognition on MUC1-expressing targets enhances cytotoxicity of a T cell subpopulation

Scandinavian Journal of Immunology

Volumn 46, Issue 1, 1997, Pages 27-34

  Bohm C M ^a   Mulder, M C ^b   Zennadi, R ^a   Notter, M ^a   Schmitt Graff A ^a   Finn, O J ^c   Taylor Papadimitriou, J ^d   Stein, H ^a   Clausen, H ^e   Riecken, E O ^a   Hanski, C ^a,f  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; COLORECTAL CARCINOMA; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY TEST; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LYMPH NODE; LYMPHOCYTE CLONE; PRIORITY JOURNAL;

EID: 8544267896     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1996.d01-91.x     Document Type: Article

References (44)

1. Ho SB, Niehans GA, Lyftogt C et al. Heterogeneity of mucin gene expression in normal and neoplastic tissues. Cancer Res 1993;53:641-51.
2. Hull SR, Bright A, Carraway KL, Abe M, Hayes DF, Kufe DW. Oligosaccharide differences in the DF3 sialomucin antigen from normal human milk and the BT-20 human breast carcinoma cell line. Cancer Commun 1989;1:261-7.
3. Burchell J, Gendler S, Taylor-Papadimitriou J et al. Development and characterisation of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin. Cancer Res 1987;47:5476-80.
4. Taylor-Papadimitriou J, Peterson J, Arklie J, Burchell J, Ceriani RL, Bodmer WF. Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: production and reaction with cells in culture. Int J Cancer 1989;28:872-83.
5. Girling A, Bartkova J, Burchell J, Gendler S, Gillett C, Taylor-Papadimitriou J. A core protein epitope of the Polymorphic Epithelial Mucin detected by the monoclonal antibody SM-3 is selectively exposed in a range of primary carcinomas. Int J Cancer 1989;43:1072-6.
6. Jerome KR, Barnd DL, Bendt KM et al. Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells. Cancer Res 1991;51:2908-16.
7. Barnd DL, Lan MS, Metzgar RS, Finn OJ. Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells. Proc Natl Acad Sci 1989;86:7159-63.
8. Ioannides CG, Fisk B, Jerome KR, Irimura T, Wharton JT, Finn OJ. Cytotoxic T cells from ovarian malignant tumors can recognize polymorphic epithelial mucin core peptides. J Immunol 1993;151: 3693-703.
9. Bu D, Domenech N, Lewis J, Taylor-Papadimitriou J, Finn OJ. Recombinant vaccinia mucin vector: In vitro analysis of expression of tumor-associated epitopes for antibody and human cytotoxic T-cell recognition. J Immunotherapy 1993;14:127-35.
10. Domenech N, Henderson RA, Finn OJ. Identification of an HLA-A11-restricted epitope from the tandem repeat domain of the epithelial tumor antigen mucin. J Immunol 1995;155:4766-74.
11. Apostopoulos V, Xing PX, McKenzie IFC. Murine response to cells transfected with human MUC1: Immunisation with cellular and synthetic antigens. Cancer Res 1994;54:5186-93.
12. Acres BR, Hareuveni M, Balloul J-M, Kieny M-P. Vaccinia Virus MUC1 immunization of mice: immune response and protection against the growth of murine tumors bearing the MUC1 antigen. J Immunotherapy 1993;14:136-43.
13. Apostopoulos V, Loveland BE, Pietersz GA, McKenzie IFC. Cytotoxic T lymphocytes in mice immunized against human MUC1 are MHC restricted. J Immunol 1995;155:5089-94.
14. Rughetti A, Turchi V, Ghetti CA et al. Human B-cell immune response to the polymorphic epithelial mucin. Cancer Res 1993;53:2457-9.
15. Kotera Y, Fontenot JD, Pecher G, Metzgar RS, Finn OJ. Humoral immunity against a tandem repeat epitope of human mucin MUC1 in sera from breast, pancreatic, and colon cancer patients. Cancer Res 1994;54:2856-60.
16. Ben-Mahrez K, Sorokine I, Thierry D et al. Circulating antibodies against c-myc oncogene product in sera of colorectal cancer patients. Int J Cancer 1990;46:35-8.
17. Pupa SM, Menard S, Andreola S, Colnaghi MI. Antibody response against the c-erb B-2 oncoprotein in breast carcinoma patients. Cancer Res 1993;53:5864-6.
18. Disis ML, Calenoff E, McLaughlin G et al. Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer. Cancer Res 1994;54:16-20.
19. Soussi T, Legros Y, Lubin R, Ory K, Schlichtholz B. Multifactorial analysis of p53 alteration in human cancer: a review. Int J Cancer 1994;57:1-9.
20. Coulie PG, Brichard V, Van Pel A et al. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 1994;180:35-42.
21. Brichard V, Van Pel A, Wölfel T et al. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 1993;178:489-95.
22. van der Bruggen P, Traversari C, Chomez P et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991;254:1643-7.
23. Gaugler B, van den Eynde B, van der Bruggen P et al. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J Exp Med 1994;179:921-30.
24. Andrews Jr CW, Jessup MJ, Goldman H et al. Localization of tumor-associaied glycoprotein DF3 in normal, inflammatory and neoplastic lesions of the colon. Cancer 1993;72:3185-90.
25. Nakamori S, Ota DM, Cleary KR, Shirotani K, Irimura T. MUC1 Mucin expression as a marker of progression and metastasis of human colorectal carcinoma. Gastroenterology 1994;106:353-61.
26. Boland CR, Deshmukh GD. The carbohydrate composition of mucin in colonic cancer. Gastroenterology 1990;98:1170-7.
27. Zotter S, Lossnitzer A, Kunze KD et al. Epithelial markers for paraffin-embedded tissues. Virchows Arch Pathol Anat 1985;406:237-51.
28. Jerome KR, Bu D, Finn OJ. Expression of tumor-associated epitopes on Epstein-Barr virus-immortalized B-cells and Burkitt's lymphomas transfected with epithelial mucin complementary DNA. Cancer Res 1992;52:5985-90.
29. Kuan SF, Byrd JC, Basbaum C, Kim YS. Inhibition of mucin glycosylation by aryl-Nacetyl-α-galactosaminides in human colonic cancer cells. J Biol Chem 1989;264:19271-7.
30. Xing PX, Tjandra JJ, Stacher SA et al. Monoclonal antibodies reactive with mucin expressed in breast cancer. Immunol Cell Biol 1989;67:183-95.
31. Apostolopoulos V, Xing PX, Trapani JA, McKenzie IFC. Production of anti-breast cancer monoclonal antibodies using a glutathione-S-transferase-MUC1 bacterial fusion protein. Br J Cancer 1993;67:713-20.
32. Burchell J, Taylor-Papadimitriou J, Boshall M, Gendler S, Duhig T. A short sequence, within the amino acid tandem repeat of cancer-associated mucin, contains immunodominant epitopes. Int J Cancer 1989;44:691-6.
33. Clausen H, Stroud M, Parker J, Springer G, Hakomori SI. Monoclonal antibodies directed to the blood group A associated structure, galactosyl-A: specificty and relation to the Thomsen-Friedenreich antigen. Mol Immunol 1988;25:199-206.
34. Henderson R, Nimgaonkar MT, Watkins SC, Robbins PD, Ball ED, Finn OJ. Human dendritic cells genetically engineered to express high levels of the human epithelial tumor antigen mucin (MUC-1). Cancer Res. 1996;56:3763-70.
35. van de Wiel-van Kemenade E, Ligtenberg JL, de Boer AJ et al. Episialin (MUC1) inhibits cytotoxic lymphocyte-target cell interaction. J Immunol 1993;151:767-76.
36. Wesseling J, van der Valk SW, Vos HL, Sonnenberg A, Hilkens J. Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components. J Cell Biol 1995;129:255-65.
37. Huang J, Byrd JC, Yoon W-H, Kim YS. Effect of Benzyl-α-GalNAc, an inhibitor of mucin glycosylation, on cancer-associated antigens in human colon cancer cells. Oncol Res 1992;4:507-15.
38. Rudd PM, Fortune F, Patel T, Parekh RB, Dwek RA, Lehner T. A human T-cell receptor recognizes "O"-linked sugars from the hinge region of human IgA1 and IgD. Immunology 1994;83:99-106.
39. Lanier LL, Chang C, Phillips JH. Human NKR-P1A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. J Immunol 1994;153:2417-28.
40. Bezouska K, Yuen CT, O'Brien J et al. Oligosaccharide ligands for NKR-P1 protein activate NK cells and cytotoxicity. Nature 1994;372:150-7.
41. Suzuki N, Yamamoto K, Toyoshima S, Osawa T, Irimura T. Molecular cloning and expression of cDNA encoding human macrophage C-type lectin. J Immunol 1996;156:128-35.
42. Gumperz JE, Parham P. The enigma of the natural killer cells. Nature 1995;378:245-8.
43. Regimbald LH, Pilarski LM, Longenecker BM, Reddish MA, Zimmermann G, Hugh JC. The breast mucin MUC1 as a novel adhesion ligand for endothelial intercellular adhesion molecule 1 in breast cancer. Cancer Res 1996;56:4244-9.
44. Hahn S, Gehri R, Erb P. Mechanism and biological significance of CD4-mediated cytotoxicity. Immunol Rev 1995;146:57-77.